Oneness Biotech Co., Ltd. (TPEX:4743)
48.10
+1.00 (2.12%)
Oct 8, 2026, 1:30 PM CST
Oneness Biotech Market Cap
Oneness Biotech has a market cap or net worth of 23.06 billion as of October 8, 2026. It is the 12,353rd most valuable company in the world and the 406th biggest in Taiwan. Its market cap has decreased by 25.69% in one year.
Market Cap
23.06B
Enterprise Value
18.13B
Revenue
153.78M
Global Rank
Country Rank
#406 Taiwan
PE Ratio
379.24
ChartMarket Cap Chart
Since June 22, 2009, Oneness Biotech's market cap has increased from 1.24B to 23.06B, an increase of 1,760.37%. That is a compound annual growth rate of 18.40%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 8, 2026 | 23.06B | -13.29% |
| Dec 31, 2025 | 26.60B | -36.18% |
| Dec 31, 2024 | 41.68B | -52.65% |
| Dec 29, 2023 | 88.03B | -7.55% |
| Dec 30, 2022 | 95.22B | -13.04% |
| Dec 30, 2021 | 109.49B | 21.98% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| CHO Pharma | 25.79B |
| Sunmax Biotechnology | 21.51B |
| Medigen Vaccine Biologics | 19.86B |
| Steminent Biotherapeutics | 17.36B |
| TaiMed Biologics | 16.39B |
| Ever Supreme Bio Technology | 16.12B |
| Gongwin Biopharm Holdings | 15.44B |
| EirGenix | 15.14B |